These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25342855)

  • 41. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
    Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
    Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Healing course of acute vessel wall injury after drug-eluting stent implantation assessed by optical coherence tomography.
    De Cock D; Bennett J; Ughi GJ; Dubois C; Sinnaeve P; Dhooge J; Desmet W; Belmans A; Adriaenssens T
    Eur Heart J Cardiovasc Imaging; 2014 Jul; 15(7):800-9. PubMed ID: 24497520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late-acquired incomplete stent apposition after everolimus-eluting stent versus sirolimus-eluting stent implantation in patients with non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction.
    Hur SH; Lee BR; Kim SW; Hong YJ; Bae JH; Choi D; Kang HJ; Choi SY; Lee SG; Kim DI; Park JS; Rha SW
    EuroIntervention; 2016 Oct; 12(8):e979-e986. PubMed ID: 26403637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study.
    Ozaki Y; Okumura M; Ismail TF; Naruse H; Hattori K; Kan S; Ishikawa M; Kawai T; Takagi Y; Ishii J; Prati F; Serruys PW
    Eur Heart J; 2010 Jun; 31(12):1470-6. PubMed ID: 20363765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Everolimus- versus Sirolimus-eluting stents in the provisional Bifurcation stenting guided by intravascular ultrasound: mid-term results of the J-REVERSE registry.
    Murasato Y; Kinoshita Y; Yamawaki M; Shinke T; Otake H; Takeda Y; Fujii K; Yamada S; Shimada Y; Yamashita T; Yumoto K
    Cardiovasc Interv Ther; 2016 Jan; 31(1):1-12. PubMed ID: 25998890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.
    Gomez-Lara J; Radu M; Brugaletta S; Farooq V; Diletti R; Onuma Y; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Sep; 4(9):992-1001. PubMed ID: 21939939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.
    Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
    Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis.
    Sato T; Tölg R; El-Mawardy M; Sulimov DS; Richardt G; Abdel-Wahab M
    J Cardiol; 2017 Nov; 70(5):454-460. PubMed ID: 28476635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparisons of detailed arterial healing response at seven months following implantation of an everolimus- or sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction.
    Sawada T; Shinke T; Otake H; Mizoguchi T; Iwasaki M; Emoto T; Terashita D; Mizuguchi T; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
    Int J Cardiol; 2013 Sep; 168(2):960-6. PubMed ID: 23164597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).
    Di Lorenzo E; Sauro R; Capasso M; Lanni F; Lanzillo T; Carbone G; Manganelli F; Palmieri V; Serino V; Pagliuca MR; Rosato G; Suryapranata H; De Luca G
    Int J Cardiol; 2016 Jan; 202():177-82. PubMed ID: 26397405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.